Literature DB >> 23105201

The relevance of apolipoprotein E polymorphism to Alzheimer's disease.

S Narayanan1.   

Abstract

The apo E gene located on chromosome 19 in humans is polymorphic. The three apo E isoforms E2, E3, and E4 are coded by three common alleles of the gene. The amyloid plaques in brains of Alzheimer disease (AD) patients are known to contain apo E. There is an increased prevalence of E4 allele in AD patients. apo E exhibits increased binding to a peptide Aβ deriving from amylold precursor protein. apo E, the risk factor for late AD disease is unable to prevent formation of paired helical filaments which in turn destabilizes neuronal microtubules.A variety of molecular techniques are available for apo E genotyping using DNA amplified by the polymerase chain reaction (PCR). The high guanine to cytosine content of apo E is problematic to the extent that the yield of PCR product and hybridization stringency can be compromised. The specificity of diagnosis of late-onset AD can be improved when results of apo E genotyping are evaluated together with clinical criteria.

Entities:  

Year:  1999        PMID: 23105201      PMCID: PMC3453560          DOI: 10.1007/BF02869150

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  21 in total

1.  Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis.

Authors:  G G Donohoe; A Salomäki; T Lehtimäki; K Pulkki; V Kairisto
Journal:  Clin Chem       Date:  1999-01       Impact factor: 8.327

2.  Molecular epidemiology of Alzheimer's disease.

Authors:  B T Hyman; R Tanzi
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

3.  Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus.

Authors:  C Snowden; R S Houlston; M H Arif; M F Laker; S E Humphries; K G Alberti
Journal:  Clin Chim Acta       Date:  1991-01-31       Impact factor: 3.786

4.  The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.

Authors:  E Boerwinkle; S Visvikis; D Welsh; J Steinmetz; S M Hanash; C F Sing
Journal:  Am J Med Genet       Date:  1987-07

5.  Apolipoprotein E phenotyping: a word of caution.

Authors:  P R Wenham; A Sedky; R J Spooner
Journal:  Ann Clin Biochem       Date:  1991-11       Impact factor: 2.057

Review 6.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

7.  High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis.

Authors:  M K Bolla; L Haddad; S E Humphries; A F Winder; I N Day
Journal:  Clin Chem       Date:  1995-11       Impact factor: 8.327

8.  Rapid identification of the common apo E isoform genotype using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP).

Authors:  R Aozaki; R Kawaguchi; U Ogasa; K Hikiji; N Kubo; I Sakurabayashi
Journal:  Mol Cell Probes       Date:  1994-02       Impact factor: 2.365

9.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Authors:  J K Boyles; R E Pitas; E Wilson; R W Mahley; J M Taylor
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

Authors:  T Polvikoski; R Sulkava; M Haltia; K Kainulainen; A Vuorio; A Verkkoniemi; L Niinistö; P Halonen; K Kontula
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

View more
  1 in total

1.  Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage.

Authors:  S Narayanan
Journal:  Indian J Clin Biochem       Date:  1999-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.